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Abstract
Emphysematous cystitis (EC) is the presence of intramural gas, with or without luminal gas, within the bladder as a
result of a primary infection of the lower urinary tract with a gas-producing organism. It is a well-recognised
complication of urinary tract infections involving Escherichia coli in diabetic patients. Clinical subcutaneous
emphysema is a rare complication of EC that appears to have poor prognosis. Only careful clinical judgement, and
a high degree of suspicion, will lead to its early diagnosis and treatment. Here, we report a case of subcutaneous
emphysema due to EC based on a clinical diagnosis confirmed using computed tomography (CT).
Introduction
Emphysematous cystitis (EC) is the presence of intramural
gas, with or without luminal gas, within the bladder as a
result of a primary infection of the lower urinary tract
with a gas-producing organism. The spectrum of clinical
presentation of EC is non-specific and can range from
minimally symptomatic urinary tract infection (UTI) to a
scenario of peritonitis and septic shock [1]. Here, we
report a case of subcutaneous emphysema due to EC
based on a clinical diagnosis confirmed using computed
tomography (CT).
Case report
An 81-year-old lady with poorly controlled non-insulin
dependent diabetes presented to our accident and emer-
gency department with increased frailty and confusion fol-
lowing review by her GP. She had been discharged 10 days
earlier following treatment for a lower respiratory tract
infection. In view of her deterioration, her GP was con-
cerned that her decline may have been attributable to an
occult infection or neoplasm. She was observed to have
bilateral pitting oedema. On assessment in hospital, the
patient was described as being “cushingoid” in appearance,
and there was generalised crepitus on abdominal palpation
to the infra-mammary region. The remainder of the clinical
examination was unremarkable.
A CT scan was requested to define the aetiology of the
clinical findings. The CT scan demonstrated a hugely
distended bladder with an air fluid level and intramural
gas (Figure 1a). In addition, gas was observed in several
other bodily compartments; in the anterior abdominal wall
(Figure 1b), intra-abdominal but extra-peritoneal (no free
intraperitoneal gas), infra-peritoneal (within the pelvis),
and the femoral canal (Figure 1c).
Au r i n ec u l t u r eg r e wEscherichia coli (E. coli), and on
the basis of sensitivities the patient was started on a
course of gentamicin and ciprofloxacin. Over the ensuing
2 days she continued to deteriorate, and the white cell
count remained raised (WCC 13.5 × 10
9/l). On the advice
of the on-call surgical team and the consultant microbiol-
ogist, the antibiotic regimen was changed to intravenous
ceftazidine and metronidazole with oral cefalexin.
Although it was a possibility, there was no evidence to
suggest the presence of an enterovesical fistula, and her
physical frailty precluded invasive investigation.
Three days later she developed right-sided pneumonia,
for which she was started on a course of oral clarithromy-
cin. In consultation with family it was decided to treat the
patient conservatively. All intravenous antibiotics were
stopped, and the patient passed away 5 days later (a total
of 21 days after her most recent admission).
Prior to this admission and above diagnoses, the
patient’s other significant medical history included essen-
tial hypertension, diverticulosis, leg cramps, orthostatic
pedal oedema, previous mastectomy of the left breast for
invasive ductal carcinoma, right delta shoulder joint
replacement following a rotator cuff tear and hiatus her-
nia. She was on once daily glimerpiride 4 mg, simvastatin
40 mg, quinine sulphate 300 mg, amiloride 50 mg and
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provided the original work is properly cited.frusemide 40 mg; twice daily loperamide 2 mg, metfor-
min 1 g and ranitidine 150 mg; and three times daily
metoclopramide 10 mg and temezepam 10 mg pro re
nata.
Discussion
While there have been over 130 cases of EC documen-
ted in the literature [1], there has only ever been, up to
now, one published case report of EC presenting with
subcutaneous emphysema [2]. Using plain radiographs
and a cystogram, this earlier case report from 1978
described luminal and possible intramural gas within
the bladder and the presence of subcutaneous emphy-
sema in the absence of a possible vesicoenteric fistula.
We report the first case of subcutaneous emphysema
due to EC based on a clinical diagnosis confirmed using
CT.
Emphysematous cystitis, per se, was first described in
1671 when a patient was said to have passed wind (i.e.,
intraluminal gas) through his urethra [3]. A little later in
the 1800s intramural gas was discovered on autopsy [4].
And in 1961 a review [5] of multiple cases concluded
that the two conditions (i.e. intraluminal and intramural
gas) were manifestations of a single disease. The clinical
presentation of EC is variable; approximately 53% of
cases present with classical symptoms of urinary tract
infection [6], whilst others may present with an acute
abdomen [7]. Up to 7% of cases are asymptomatic and
are diagnosed on the basis of an incidental finding on
abdominal/pelvic imaging [6].
In spite of the variation in clinical presentation of EC,
type 2 diabetes mellitus has been shown to be present
in 2/3 of all cases, and of these 64% were women [1,6].
T h e s ef i g u r e sm a yw e l lb ee v e nh i g h e ra sa1 / 3o fa l l
cases of diabetes mellitus are undiagnosed [8]. More-
over, with the predicted doubling of the prevalence of
type 2 diabetes from 1995 to 2025 [9], clinicians need to
be aware of its role as possible pathological basis for a
complicated or un-resolving UTI.
It is postulated that the presence of gas-producing
organisms in conjunction with high glucose or albumin
concentrations (both bacterial substrates) favours the
development of emphysematous infections within the
urinary tract [10]. In 90% of cases of EC a urinary tract
pathogen was isolated [6], and E. coli was the most pre-
valent pathogen (57%). It may very well be that the
remaining 10% of cases where a urinary tract pathogen
was not isolated may be attributable to detection failure.
Indeed, it was only on the second urine culture that
E. coli was isolated in our case.
It is tempting to speculate the anatomical route taken
by the perivesicular gas to produce the radiological ima-
ging observed in this case study. It is probable that the
carbon dioxide bubbles produced as a result of urinary
Figure 1 Radiographic imaging of subcutaneous emphysema
secondary to emphysematous cystitis. a CT sagittal section
showing gas within the anterior abdominal wall and within the
bladder lumen and wall. b CT coronal section showing gas within
abdominal wall outside the muscle layer, intra-abdominal but
retroperitoneal, and within the bladder wall. c CT axial section
showing gas within the bladder base and femoral canal.
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cosa of the bladder and out into the infra-peritoneal
space around the bladder base. Once here these bubbles
may move across and diffuse into and through abdom-
inal musculature. Similarly they may move down into
the ischiorectal fossa or up through the retroperitoneal
paravertebral tissues into the posterior mediastinum [2].
The management of EC has remained unchanged over
the last 30 years [2], with broad-cover intravenous anti-
biotics being used until urinary pathogen sensitivities are
known. Concurrently, the bladder should be drained and
blood glucose levels should be controlled. Between 10-
20% of documented patients with EC underwent surgical
debridement [1,6]. As carbon dioxide is absorbed readily
in human tissue, eventual resolution should occur follow-
ing antibiotic elimination of the infecting pathogen;
hence, the precise role of surgical intervention is not
clear. By itself, EC usually runs a benign course with an
overall death rate of 7% [1]; this however rises to almost
50% when perivesicular gas migrates up the urinary tract
or when gas-producing organisms infect the kidneys
[11,12]. It is likely that patients with EC with extensive
emphysematous changes will have a worse prognosis
because of the greater distribution of perivesicular gas.
Conclusion
In conclusion, clinical subcutaneous emphysema is a rare
complication of EC that appears to have poor prognosis.
Only careful clinical judgement, and a high degree of sus-
picion, will lead to its early diagnosis and treatment. Its
true incidence and specific management can only be
determined by greater awareness of its presence as a rare
but important complication of urinary tract infection,
especially in patients with poorly controlled diabetes.
The use of CT has identified that the term subcutaneous
emphysema does not convey the extent of perivesicular
emphysema, and we suggest the term “multi-compartment
emphysema” more accurately describes our findings.
Key points
1. Emphysematous cystitis is a well-recognised com-
plication of urinary tract infections involving E. coli
in diabetic patients.
2. Computed tomography is ideal in defining vesicu-
lar and perivesicular emphysema.
3. Prompt aggressive management using intravenous
antibiotics is the most appropriate way to treat EC.
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